Ocular allergy/inflammation:
Indications for: BROMSITE
Post-operative inflammation and prevention of ocular pain following cataract surgery.
Adult Dosage:
≥18yrs: 1 drop in affected eye twice daily starting 1 day before surgery, continued on day of surgery, and for 14 days post-op. May be given with other topical ophthalmics (eg, alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, mydriatics); administer at least 5 mins apart.
Children Dosage:
<18yrs: not established.
BROMSITE Warnings/Precautions:
Bleeding tendencies. May slow or delay wound healing. Potential for cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, other NSAIDs. Complicated/repeat ocular surgeries. Corneal defects/denervation. Ocular surface diseases. Rheumatoid arthritis. Diabetes. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Risk of corneal adverse events may be increased if used >24hrs before surgery, or beyond 14-days post-op. Contact lenses (remove during therapy). Pregnancy: avoid during late pregnancy. Nursing mothers.
BROMSITE Classification:
NSAID.
BROMSITE Interactions:
Concomitant topical NSAIDs and corticosteroids may potentiate healing problems. Caution with concomitant drugs that prolong bleeding time.
Adverse Reactions:
Anterior chamber inflammation, headache, vitreous floaters, iritis, eye pain, ocular hypertension; keratitis, corneal reactions (eg, epithelial breakdown, thinning, erosion, ulceration/perforation).
Generic Drug Availability:
NO
How Supplied:
Soln—5mL
